Latest news

Classic list

Globally incubate standards compliant channels before scalable benefits. Quickly disseminate superior deliverables whereas web-enabled applications.

Latest news

News

Credibly innovate granular internal or “organic“ sources whereas high standards in web-readiness. Energistically scale future-proof core competencies.


May 14, 2023 Publications

Acen, E. L., Biraro, I. A., Bbuye, M., Kateete, D. P., Joloba, M. L., & Worodria, W. (2022). Hypovitaminosis D among newly diagnosed pulm7onary TB patients and their household contacts in Uganda. Scientific Reports12(1), 1–8. https://doi.org/10.1038/s41598-022-09375-7

Acen, E. L., Kateete, D. P., Worodria, W., Olum, R., Joloba, M. L., Bbuye, M., & Biraro, I. A. (2022). Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda. Plos One17(8), e0272788. https://doi.org/10.1371/journal.pone.0272788

Bulage, L., Imoko, J., Joloba, M. L., Kirenga, B. J., Lo, T., Byabajungu, H., … Bloss, E. (2015). Quality of Sputum Specimen Samples Submitted for Culture and Drug Susceptibility Testing at the National Tuberculosis Reference Laboratory-Uganda, July-October 2013. Journal of Tuberculosis Research03(03), 97–106. https://doi.org/10.4236/jtr.2015.33015

Kabahita, J. M., Kabugo, J., Joloba, M. L., Kakooza, F., Adam, I., Guido, O., … Mboowa, G. (2022). First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. Antimicrobial Resistance and Infection Control11(1), 1–8. https://doi.org/10.1186/s13756-022-01101-2

Kamulegeya, R., Kateete, D. P., Bagaya, B. S., Nasinghe, E., Muttamba, W., Nsubuga, G., … Joloba, M. L. (2022). Biobanking: Strengthening Uganda’s Rapid Response to COVID-19 and Other Epidemics. Biopreservation and Biobanking20(3), 238–243. https://doi.org/10.1089/bio.2021.0022

Katongole, P., Sande, O. J., Nabweyambo, S., Joloba, M., Kajumbula, H., Kalungi, S., … Niyonzima, N. (2022). IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute. Future Oncology18(6), 661–667. https://doi.org/10.2217/fon-2021-0683

Katongole, P., Sande, O. J., Reynolds, S. J., Joloba, M., Kajumbula, H., Kalungi, S., … Niyonzima, N. (2022). Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men. Oncology and Therapy10(1), 185–193. https://doi.org/10.1007/s40487-022-00184-6

Masiga, F., Kigozi, E., Najjuka, C. F., Kajumbula, H., & Kateete, D. P. (2022). Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda. African Health Sciences22(1), 581–588. https://doi.org/10.4314/ahs.v22i1.67

Mbiine, R., Wayengera, M., Ocan, M., Kiwanuka, N., Munabi, I., Muwonge, H., … Joloba, M. (2022). Adipose-derived stromal vascular fraction ( SVF ) in scar treatment : a systematic review protocol, 11(4), 56–63. https://pubmed.ncbi.nlm.nih.gov/36189175

Mujuni, D., Kasemire, D. L., Joloba, M. L., Ibanda, I., Kabugo, J., Nsawotebba, A., … Ssengooba, W. (2022). Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review. BMC Infectious Diseases22(1), 1–10. https:// doi.org/10.1186/s12879-022-07339-w

Musisi, E., Sessolo, A., Kaswabuli, S., Joloba, M. L., Zawedde, J., Byanyima, P., … Sabiiti, W. (2022). High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis. Microbiology Spectrum10(1), 1–12. https://doi.org/10.1128/spectrum.02100-21

Mutayoba, B. K., Michael Hoelscher, Heinrich, N., Joloba, M. L., Lyamuya, E., Kilale, A. M., … Pletschette, M. (2022). Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania. BMC Genomics23(1), 1–9. https://doi.org/10.1186/s12864-022-08791-3

Muwonge, H., Kasujja, H., Niyonzima, N., Kateete, D. P., Atugonza, C., Kasolo, J., … Bwanga, F. (2022). Unique circulating microRNA profiles in epidemic Kaposi’s sarcoma. Non-Coding RNA Research7(2), 114–122. https://doi.org/10.1016/j.ncrna.2022.02.002

Nabakooza, G., Pastusiak, A., Kateete, D. P., Lutwama, J. J., Kitayimbwa, J. M., & Frost, S. D. W. (2022). Whole-genome analysis to determine the rate and patterns of intra-subtype reassortment among influenza type-A viruses in Africa. Virus Evolution8(1), 1–15. https://doi.org/10.1093/ve/veac005

Najjuka, S. M., Ngabirano, T. D., Balizzakiwa, T., Nabadda, R., Kaggwa, M. M., Kateete, D. P., … Kiguli, S. (2022). Health Care Workers’ Perceived Self-Efficacy to Manage COVID-19 Patients in Central Uganda: A Cross-Sectional Study. Risk Management and Healthcare Policy15(June), 1253–1270. https://doi.org/10.2147/RMHP.S356410

Nantale, M., Joloba, M. L., Diana, B., Talemwa, N., Tania, R., Achilles, K., … Sara, A. (2022). Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis, 385(26), 2441–2450. https://doi. org/10.1056/NEJMoa2105470.Multicomponent

Perier, C., Nasinghe, E., Joloba, M. L., Charles, I., Ssetaba, L. J., Ahyong, V., … Schaletzky, J. (2022). Workshop-based learning and networking: a scalable model for research capacity strengthening in low-and middle-income countries. Global Health Action15(1). https://doi.org/10.1080/16549716.2022.206 2175

Pitzer, A., Elijovich, F., Laffer, C. L., Ertuglu, L. A., Sahinoz, M., Saleem, M., … Kirabo, A. (2022). DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension. Circulation Research131(4), 328–344. https://doi.org/10.1161/CIRCRESAHA.122.320818

Wayengera, M., Babirye, P., Musubika, C., Kirimunda, S., & L. Joloba, M. (2019). Cloning, Expression and Purification of Recombinant Forms of Full Length and Extracellular Domain EBOV Glycoprotein within Mammalian Cell-Lines. Journal of Antivirals & Antiretrovirals11(3), 1–8. https://doi.org/10.35248/1948-5964.19.11.187

Matovu B, Takuwa M, Mpaata CN, Denison F, Kiwanuka N, Lewis S, Norrie J, Ononge S, Muhimbise O, Tuck S, Etuket MD. Review of investigational medical devices’ clinical trials and regulations in Africa as a benchmark for new innovations. Frontiers in Medical Technology. 2022;4.

Takuwa M, Mbabazi SE, Tusabe M, Mulindwa B, Makobore PN, Mulerwa M, Kansiime EC, Birungi DM, Reboud J, Cooper J, Robert S. Mobile health access and utilisation in Uganda: knowledge, attitudes and perceptions of health and veterinary workers. Telemedicine and e-Health. 2022.

Morgado Ramirez DZ, Nakandi B, Ssekitoleko R, Ackers L, Mwaka E, Kenney L, Holloway C, Donovan-Hall M. The lived experience of people with upper limb absence living in Uganda: A qualitative study. African Journal of Disability. 2022 May 20;11:890.

Kiwumulo HF, Muwonge H, Ibingira C, Lubwama M, Kirabira JB, Ssekitoleko RT. Green synthesis and characterization of iron-oxide nanoparticles using Moringa oleifera: a potential protocol for use in low and middle income countries. BMC Research Notes. 2022 Dec;15(1):1-8.

Owino SC, Etuket MD, Muhimbise O, Kiwanuka M, Arinda BN, Mukiibi D, Kiwanuka N, Ssekitoleko RT, Ononge S. The Usability, Acceptability, and Performance of the Maternal PPH Wrap Device in Controlling Postpartum Hemorrhage: A Pilot Study at Kawempe National Referral Hospital, Uganda. IEEE Journal of Translational Engineering in Health and Medicine. 2022 Aug 16;10:1-7.

Mujuni, D., Kasemire, D. L., Ibanda, I., Kabugo, J., Nsawotebba, A., Phelan, J. E., … & Ssengooba, W. (2022). Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review. BMC Infectious Diseases22(1), 1-10.

Acen, E. L., Kateete, D. P., Worodria, W., Olum, R., Joloba, M. L., Bbuye, M., & Biraro, I. A. (2022). Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda. PloS one17(8), e0272788.

Acen, E. L., Biraro, I. A., Bbuye, M., Kateete, D. P., Joloba, M. L., & Worodria, W. (2022). Hypovitaminosis D among newly diagnosed pulmonary TB patients and their household contacts in Uganda. Scientific reports12(1), 5296.

Kabahita, J. M., Kabugo, J., Kakooza, F., Adam, I., Guido, O., Byabajungu, H., … & Mboowa, G. (2022). First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. Antimicrobial Resistance & Infection Control11(1), 68.

Jjingo, D., Mboowa, G., Sserwadda, I., Kakaire, R., Kiberu, D., Amujal, M., … & Whalen, C. C. (2022).

Bioinformatics mentorship in a resource limited setting. Briefings in Bioinformatics23(1), bbab399.

Mutayoba, B. K., Hoelscher, M., Heinrich, N., Joloba, M. L., Lyamuya, E., Kilale, A. M., … & Pletschette, M. (2022). Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania. BMC genomics23(1), 1-9.

Musisi, E., Sessolo, A., Kaswabuli, S., Zawedde, J., Byanyima, P., Kasinga, S., … & Sabiiti, W. (2022). High mycobacterium tuberculosis bacillary loads detected by tuberculosis molecular bacterial load assay in patient stool: a potential alternative for nonsputum diagnosis and treatment response monitoring of tuberculosis. Microbiology spectrum10(1), e02100-21.

Bongomin, F., Kwizera, R., Mande, E., Aloyo, S. M., Achan, B., Namusobya, M., … & Kirenga, B. J. (2022). Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda. African Health Sciences22(3), 506-511.

Thompson, R. R., Nalugwa, T., Oyuku, D., Tucker, A., Nantale, M., Nakaweesa, A., … & Sohn, H. (2023). Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis. The Lancet Global Health11(2), e278-e286.

Kateete, D. P., Kimani, C. N., Katabazi, F. A., Okeng, A., Okee, M. S., Nanteza, A., … & Najjuka, F. C. (2010). Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test. Annals of clinical microbiology and antimicrobials9(1), 1-7.

Kirenga, B., Muttamba, W., Kayongo, A., Nsereko, C., Siddharthan, T., Lusiba, J., … & Bazeyo, W. (2020). Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda. BMJ open respiratory research7(1), e000646.

Kateete, D. P., Nakanjako, R., Okee, M., Joloba, M. L., & Najjuka, C. F. (2017). Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda. BMC research notes10, 1-10.

Stein, C. M., Zalwango, S., Malone, L. L., Thiel, B., Mupere, E., Nsereko, M., … & Mayanja-Kizza, H. (2018). Resistance and susceptibility to Mycobacterium tuberculosis infection and disease in tuberculosis households in Kampala, Uganda. American journal of epidemiology187(7), 1477-1489.

Traore, H., Ogwang, S., Mallard, K., Joloba, M. L., Mumbowa, F., Narayan, K., … & McNerney, R. (2007). Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Annals of Clinical Microbiology and antimicrobials6(1), 1-6.

Nabakooza, G., Pastusiak, A., Kateete, D. P., Lutwama, J. J., Kitayimbwa, J. M., & Frost, S. D. W. (2022). Whole-genome analysis to determine the rate and patterns of intra-subtype reassortment among influenza type-A viruses in Africa. Virus Evolution8(1), veac005.

Kafeero, H. M., Ndagire, D., Ocama, P., Kato, C. D., Wampande, E., Kajumbula, H., … & Sendagire, H. (2022). Disproportionate distribution of HBV genotypes A and D and the recombinant genotype D/E in the high and low HBV endemic regions of Uganda: A wake-up call for regional specific HBV management. International Journal of Hepatology2022.

Najjuka, S. M., Ngabirano, T. D., Balizzakiwa, T., Nabadda, R., Kaggwa, M. M., Kateete, D. P., … & Kiguli, S. (2022). Health care workers perceived self-efficacy to manage COVID-19 patients in central uganda: a cross-sectional study. Risk Management and Healthcare Policy, 1253-1270.

Nakku-Joloba, E., Mboowa, G., Ssengooba, W., Kiyimba, A., Kigozi, E., Baluku, H., … & Kateete, D. P. (2022). Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda. African Health Sciences22(3), 62-71.

Galiwango, R., Bainomugisha, E., Kivunike, F., Kateete, D. P., & Jjingo, D. (2022). Air pollution and mobility patterns in two Ugandan cities during COVID-19 mobility restrictions suggest the validity of air quality data as a measure for human mobility. Environmental Science and Pollution Research, 1-16.

Nabakooza, G., Galiwango, R., Frost, S. D., Kateete, D. P., & Kitayimbwa, J. M. (2022). Molecular Epidemiology and Evolutionary Dynamics of Human Influenza Type-A Viruses in Africa: A Systematic Review. Microorganisms10(5), 900.

Kwizera, A., Kateete, D. P., Ssenyonga, R., Nakiyingi, L., Nakibuuka, J., Namata, C., … & Summers, C. (2022). Acute respiratory distress syndrome in an African intensive care unit setting: a prospective study of prevalence and outcomes. Annals of the American Thoracic Society19(4), 691-694.

Kamulegeya, R., Kateete, D. P., Bagaya, B. S., Nasinghe, E., Muttamba, W., Nsubuga, G., … & Joloba, M. L. (2022). Biobanking: Strengthening Uganda’s Rapid Response to COVID-19 and Other Epidemics. Biopreservation and Biobanking20(3), 238-243.

Perier, C., Nasinghe, E., Charles, I., Ssetaba, L. J., Ahyong, V., Bangs, D., … & Schaletzky, J. (2022). Workshop-based learning and networking: a scalable model for research capacity strengthening in low-and middle-income countries. Global Health Action15(1), 2062175.

Namaganda, M. M., Sendagire, H., Kateete, D. P., Kigozi, E., Nsubuga, M. L., Katabazi, F. A., … & Mboowa, G. (2022). Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in Uganda. F1000Research11(901), 901.

Achan, B., Mboowa, G., Kwizera, R., Kateete, D. P., Kajumbula, H., & Bongomin, F. (2022). Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda. IJID Regions3, 261-264.

Ssekagiri, A., Jjingo, D., Lujumba, I., Bbosa, N., Bugembe, D. L., Kateete, D. P., … & Ssemwanga, D. (2022). QuasiFlow: a Nextflow pipeline for analysis of NGS-based HIV-1 drug resistance data. Bioinformatics Advances2(1), vbac089.

Masiga, F., Kigozi, E., Najjuka, C. F., Kajumbula, H., & Kateete, D. P. (2022). Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda. African Health Sciences22(1), 581-8.

Mukasa Kafeero, H., Ndagire, D., Ocama, P., Drago, C. K., Wampande, E., Kajumbula, H., … & Sendagire, H. (2022). TREAT-B Algorithm for Treatment Eligibility Among the Chronically Infected Hepatitis B Virus Persons in a low and a high endemic region: A potential Strategy Towards the Virus Elimination By 2030. Frontiers in virology, 27.

Kafeero, H. M., Ndagire, D., Ocama, P., Kato, C. D., Wampande, E., Walusansa, A., … & Sendagire, H. (2022). Mapping Hepatitis B Virus Genotypes, Recombinant Genotypes and Sub-genotypes on the African continent from 1997 to 2021: A Systematic Review with Meta-Analysis.

Nsubuga, G., Kateete, D. P., Aloyo, S. M., Kigingi, L. N., Emmanuel, N., Dafala, K., … & Rogers, K. (2022). Biobanking in East and Central Africa: A case of the Integrated Biorepository of H3Africa Uganda. Open Research Africa5(33), 33.




In short words


MakBRC is a Ugandan registered Not-for-Profit Organization fully owned by Makerere University established within Makerere University College of Health Sciences.



Newsletter

Please subscribe to our Newsletter.






    Copyright by MakBRC ©2025. All rights reserved.